ENTRY       hsa04620                    Pathway
NAME        Toll-like receptor signaling pathway - Homo sapiens (human)
DESCRIPTION Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified as homologs of Toll in Drosophila. Mammalian TLRs are expressed on innate immune cells, such as macrophages and dendritic cells, and respond to the membrane components of Gram-positive or Gram-negative bacteria. Pathogen recognition by TLRs provokes rapid activation of innate immunity by inducing production of proinflammatory cytokines and upregulation of costimulatory molecules. TLR signaling pathways are separated into two groups: a MyD88-dependent pathway that leads to the production of proinflammatory cytokines with quick activation of NF-{kappa}B and MAPK, and a MyD88-independent pathway associated with the induction of IFN-beta and IFN-inducible genes, and maturation of dendritic cells with slow activation of NF-{kappa}B and MAPK.
CLASS       Organismal Systems; Immune system
PATHWAY_MAP hsa04620  Toll-like receptor signaling pathway
NETWORK     nt06161  Human immunodeficiency virus 1 (HIV-1)
            nt06162  Hepatitis B virus (HBV)
            nt06163  Hepatitis C virus (HCV)
            nt06164  Kaposi sarcoma-associated herpesvirus (KSHV)
            nt06165  Epstein-Barr virus (EBV)
            nt06166  Human papillomavirus (HPV)
            nt06168  Herpes simplex virus 1 (HSV-1)
            nt06169  Measles virus (MV)
            nt06170  Influenza A virus (IAV)
            nt06171  SARS coronavirus 2 (SARS-CoV-2)
            nt06180  Pathogenic Escherichia coli
            nt06182  Shigella
            nt06183  Yersinia
            nt06222  IFN signaling (cancer)
            nt06263  Hepatocellular carcinoma
            nt06517  TLR signaling
  ELEMENT   N00148  TLR3-IRF7 signaling pathway
            N00149  TLR3-IRF3 signaling pathway
            N00150  Type I IFN signaling pathway
            N00435  TLR1/2/4-NFKB signaling pathway
            N00438  TLR2/4-MAPK signaling pathway
            N00553  TLR4-IRF3/7 signaling pathway
            N00563  TLR3-NFKB signaling pathway
            N00690  TLR7/9-IRF7 signaling pathway
            N01543  TLR7/8/9-IRF5 signaling pathway
            N01566  TLR5-NFKB signaling pathway
DRUG        D00745  Interferon alfa-2a (USAN/INN)
            D00746  Interferon beta-1b (USAN/INN)
            D01666  Bropirimine (JAN/USAN/INN)
            D02500  Imiquimod (JAN/USP/INN)
            D02744  Interferon alfacon-1 (USAN/INN)
            D02745  Interferon alfa-2b (USAN)
            D02747  Peginterferon alfa-2a (USAN/INN)
            D02748  Peginterferon alfa-2b (USAN/INN)
            D03304  Interferon beta (JAN)
            D03305  Interferon alfa (NAMALWA) (JP18)
            D03441  Certolizumab pegol (USAN/INN)
            D04043  Eritoran tetrasodium (USAN)
            D04295  Galiximab (USAN/INN)
            D04552  Interferon alfa-n1 (USAN)
            D04553  Interferon alfa-n3 (USAN)
            D04554  Interferon beta-1a (USAN)
            D04619  Isatoribine (USAN)
            D04787  Loxoribine (USAN/INN)
            D06071  Teneliximab (USAN/INN)
            D06619  Mifamurtide (USAN)
            D06634  Relacatib (USAN/INN)
            D06635  Rilonacept (USAN/INN)
            D08841  Agatolimod (USAN)
            D08842  Agatolimod sodium (USAN)
            D08844  Albinterferon alfa-2b (USAN)
            D08955  Odanacatib (JAN/USAN)
            D09573  Eritoran sodium (JAN)
            D09639  Losmapimod (USAN/INN)
            D09661  Rintatolimod (USAN/INN)
            D10483  Peginterferon beta-1a (USAN/INN)
            D11003  Vesatolimod (USAN/INN)
            D11027  Ropeginterferon alfa-2b (INN)
            D11357  Bleselumab (USAN/INN)
            D11491  Selicrelumab (USAN/INN)
            D11503  Tomaralimab (USAN)
            D11504  Tilsotolimod (USAN/INN)
            D11505  Tilsotolimod sodium (USAN)
            D11597  Ravagalimab (USAN/INN)
            D11610  Iscalimab (USAN/INN)
            D11668  Mosedipimod (USAN/INN)
            D11871  Selgantolimod (USAN/INN)
            D12167  Zimlovisertib (USAN)
            D12178  Sotigalimab (USAN)
            D12261  Enpatoran (USAN/INN)
            D12275  Cobitolimod (USAN/INN)
            D12276  Cobitolimod sodium (USAN)
            D12352  Eclitasertib (USAN/INN)
            D12411  Emavusertib (USAN/INN)
            D12412  Emavusertib hydrochloride (USAN)
            D12453  Guretolimod (USAN/INN)
            D12463  Davoceticept (USAN/INN)
            D12464  Dazukibart (USAN)
            D12521  Ruzotolimod (USAN/INN)
            D12532  Emavusertib mesylate (USAN)
            D12533  Emavusertib maleate (USAN)
            D12538  Emavusertib phosphate (USAN)
            D12539  emavusertib tosylate (USAN)
            D12624  Paridiprubart (USAN/INN)
            D12725  Lomedeucitinib (USAN)
            D12821  Flizasertib (USAN/INN)
            D12846  Ocadusertib (USAN)
            D12855  Nelitolimod (USAN)
            D12856  Nelitolimod sodium (USAN)
            D12929  Vamikibart (USAN/INN)
            D12936  Vidutolimod (USAN/INN)
            D12940  Oditrasertib (USAN/INN)
            D12941  Zasocitinib (USAN/INN)
            D13033  Abiprubart (USAN/INN)
            D13049  Pacibekitug (USAN/INN)
            D13051  Resiquimod sulfate (USAN)
            D13124  Envudeucitinib hydrochloride (USAN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            10333  TLR6; toll like receptor 6 [KO:K10169]
            10379  IRF9; interferon regulatory factor 9 [KO:K04693]
            10454  TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1 [KO:K04403]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            114609  TIRAP; TIR domain containing adaptor protein [KO:K05403]
            1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
            1326  MAP3K8; mitogen-activated protein kinase kinase kinase 8 [KO:K04415] [EC:2.7.11.25]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]
            1513  CTSK; cathepsin K [KO:K01371] [EC:3.4.22.38]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            23118  TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2 [KO:K04404]
            2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]
            23643  LY96; lymphocyte antigen 96 [KO:K05400]
            29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]
            3439  IFNA1; interferon alpha 1 [KO:K05414]
            3440  IFNA2; interferon alpha 2 [KO:K05414]
            3441  IFNA4; interferon alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon alpha 10 [KO:K05414]
            3447  IFNA13; interferon alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon alpha 16 [KO:K05414]
            3451  IFNA17; interferon alpha 17 [KO:K05414]
            3452  IFNA21; interferon alpha 21 [KO:K05414]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            353376  TICAM2; TIR domain containing adaptor molecule 2 [KO:K05409]
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
            3553  IL1B; interleukin 1 beta [KO:K04519]
            3569  IL6; interleukin 6 [KO:K05405]
            3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]
            3592  IL12A; interleukin 12A [KO:K05406]
            3593  IL12B; interleukin 12B [KO:K05425]
            3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]
            3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]
            3661  IRF3; interferon regulatory factor 3 [KO:K05411]
            3663  IRF5; interferon regulatory factor 5 [KO:K09446]
            3665  IRF7; interferon regulatory factor 7 [KO:K09447]
            3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]
            3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
            388372  CCL4L1; C-C motif chemokine ligand 4 like 1 [KO:K12964]
            3929  LBP; lipopolysaccharide binding protein [KO:K05399]
            414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]
            4283  CXCL9; C-X-C motif chemokine ligand 9 [KO:K05416]
            4615  MYD88; MYD88 innate immune signal transduction adaptor [KO:K04729]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]
            51284  TLR7; toll like receptor 7 [KO:K05404]
            51311  TLR8; toll like receptor 8 [KO:K10170]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            54106  TLR9; toll like receptor 9 [KO:K10161]
            54472  TOLLIP; toll interacting protein [KO:K05402]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
            5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            5879  RAC1; Rac family small GTPase 1 [KO:K04392]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]
            6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]
            6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]
            6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]
            6373  CXCL11; C-X-C motif chemokine ligand 11 [KO:K12672]
            6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            6696  SPP1; secreted phosphoprotein 1 [KO:K06250]
            6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
            6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
            6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
            7096  TLR1; toll like receptor 1 [KO:K05398]
            7097  TLR2; toll like receptor 2 [KO:K10159]
            7098  TLR3; toll like receptor 3 [KO:K05401]
            7099  TLR4; toll like receptor 4 [KO:K10160]
            7100  TLR5; toll like receptor 5 [KO:K10168]
            7124  TNF; tumor necrosis factor [KO:K03156]
            7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]
            7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]
            7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]
            841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
            8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]
            8772  FADD; Fas associated via death domain [KO:K02373]
            929  CD14; CD14 molecule [KO:K04391]
            941  CD80; CD80 molecule [KO:K05412]
            942  CD86; CD86 molecule [KO:K05413]
            9560  CCL4L2; C-C motif chemokine ligand 4 like 2 [KO:K12964]
            958  CD40; CD40 molecule [KO:K03160]
            9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]
REFERENCE   PMID:17275323
  AUTHORS   Kawai T, Akira S.
  TITLE     TLR signaling.
  JOURNAL   Semin Immunol 19:24-32 (2007)
            DOI:10.1016/j.smim.2006.12.004
REFERENCE   PMID:17457343
  AUTHORS   O'Neill LA, Bowie AG.
  TITLE     The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
  JOURNAL   Nat Rev Immunol 7:353-64 (2007)
            DOI:10.1038/nri2079
REFERENCE   PMID:16932750
  AUTHORS   Honda K, Taniguchi T.
  TITLE     IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
  JOURNAL   Nat Rev Immunol 6:644-58 (2006)
            DOI:10.1038/nri1900
REFERENCE   PMID:17395581
  AUTHORS   Uematsu S, Akira S.
  TITLE     Toll-like receptors and Type I interferons.
  JOURNAL   J Biol Chem 282:15319-23 (2007)
            DOI:10.1074/jbc.R700009200
REFERENCE   PMID:16497588
  AUTHORS   Akira S, Uematsu S, Takeuchi O.
  TITLE     Pathogen recognition and innate immunity.
  JOURNAL   Cell 124:783-801 (2006)
            DOI:10.1016/j.cell.2006.02.015
REFERENCE   PMID:14698224
  AUTHORS   Yamamoto M, Takeda K, Akira S.
  TITLE     TIR domain-containing adaptors define the specificity of TLR signaling.
  JOURNAL   Mol Immunol 40:861-8 (2004)
            DOI:10.1016/j.molimm.2003.10.006
REFERENCE   PMID:12734364
  AUTHORS   Means TK, Hayashi F, Smith KD, Aderem A, Luster AD.
  TITLE     The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.
  JOURNAL   J Immunol 170:5165-75 (2003)
            DOI:10.4049/jimmunol.170.10.5165
REFERENCE   PMID:14751764
  AUTHORS   Aderem A, Smith KD.
  TITLE     A systems approach to dissecting immunity and inflammation.
  JOURNAL   Semin Immunol 16:55-67 (2004)
            DOI:10.1016/j.smim.2003.10.002
REFERENCE   PMID:17637696
  AUTHORS   Banerjee A, Gerondakis S.
  TITLE     Coordinating TLR-activated signaling pathways in cells of the immune system.
  JOURNAL   Immunol Cell Biol 85:420-4 (2007)
            DOI:10.1038/sj.icb.7100098
REFERENCE   PMID:17507094
  AUTHORS   Loniewski KJ, Patial S, Parameswaran N.
  TITLE     Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
  JOURNAL   Mol Immunol 44:3715-23 (2007)
            DOI:10.1016/j.molimm.2007.04.002
REFERENCE   PMID:11101877
  AUTHORS   Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG.
  TITLE     Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.
  JOURNAL   Nat Immunol 1:533-40 (2000)
            DOI:10.1038/82797
REFERENCE   PMID:16924467
  AUTHORS   Uematsu S, Akira S.
  TITLE     Toll-like receptors and innate immunity.
  JOURNAL   J Mol Med 84:712-25 (2006)
            DOI:10.1007/s00109-006-0084-y
REL_PATHWAY hsa04010  MAPK signaling pathway
            hsa04060  Cytokine-cytokine receptor interaction
            hsa04064  NF-kappa B signaling pathway
            hsa04120  Ubiquitin mediated proteolysis
            hsa04151  PI3K-Akt signaling pathway
            hsa04210  Apoptosis
            hsa04610  Complement and coagulation cascades
            hsa04630  JAK-STAT signaling pathway
KO_PATHWAY  ko04620
///
